Communications Biology (Apr 2023)

Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions

  • Paul S. Kwon,
  • Shirley Xu,
  • Hanseul Oh,
  • Seok-Joon Kwon,
  • Andre L. Rodrigues,
  • Maisha Feroz,
  • Keith Fraser,
  • Peng He,
  • Fuming Zhang,
  • Jung Joo Hong,
  • Robert J. Linhardt,
  • Jonathan S. Dordick

DOI
https://doi.org/10.1038/s42003-023-04789-z
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 8

Abstract

Read online

Suramin, a polysulfated synthetic drug, binds to the ACE2 receptor and heparan sulfate binding sites on SARS-CoV-2 RBDs with preferential binding for Omicron RBD and inhibition of infection by the Omicron variant in vitro.